Biofrontera Inc. (BFRI): Total Assets
$28.56M
As of 2025-12-31
$24.06M
As of 2026-06-30
-17.5%
3-year compound annual growth
+3.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $28.56M | +29.2% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $22.10M | -20.9% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $27.93M | -45.1% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $50.88M | -4.4% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $53.22M | +120.5% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $24.14M | n/a | 2022-04-11, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Biofrontera Inc. (BFRI) | 2025-12-31 | $28.56M | +29.2% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $638.50M | +81.3% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $154.69M | +117.6% |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $25.34M | +1.8% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $76.82M | +1.6% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $160.43M | +58.2% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $433.81M | +718.5% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $596.19M | +30.6% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $668.19M | -10.3% |
Compare BFRI, WVE, XLO, INBP side by side · Screen every company in Pharmaceutical Preparations ↗